Logo image of ATEX

ANTERIX INC (ATEX) Stock Fundamental Analysis

NASDAQ:ATEX - Nasdaq - US03676C1009 - Common Stock - Currency: USD

22.74  -0.04 (-0.18%)

Fundamental Rating

3

Taking everything into account, ATEX scores 3 out of 10 in our fundamental rating. ATEX was compared to 32 industry peers in the Diversified Telecommunication Services industry. While ATEX has a great health rating, there are worries on its profitability. ATEX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ATEX had negative earnings in the past year.
ATEX had a negative operating cash flow in the past year.
In the past 5 years ATEX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ATEX reported negative operating cash flow in multiple years.
ATEX Yearly Net Income VS EBIT VS OCF VS FCFATEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.41%, ATEX is doing worse than 78.13% of the companies in the same industry.
Looking at the Return On Equity, with a value of -7.26%, ATEX is in line with its industry, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
ROA -3.41%
ROE -7.26%
ROIC N/A
ROA(3y)-4.03%
ROA(5y)-9.42%
ROE(3y)-7.34%
ROE(5y)-13.55%
ROIC(3y)N/A
ROIC(5y)N/A
ATEX Yearly ROA, ROE, ROICATEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEX Yearly Profit, Operating, Gross MarginsATEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K

7

2. Health

2.1 Basic Checks

ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATEX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ATEX has been increased compared to 5 years ago.
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ATEX Yearly Shares OutstandingATEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
ATEX Yearly Total Debt VS Total AssetsATEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

ATEX has an Altman-Z score of -0.55. This is a bad value and indicates that ATEX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ATEX (-0.55) is worse than 84.38% of its industry peers.
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.55
ROIC/WACCN/A
WACC9.1%
ATEX Yearly LT Debt VS Equity VS FCFATEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

ATEX has a Current Ratio of 2.23. This indicates that ATEX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.23, ATEX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Quick Ratio of 2.23 indicates that ATEX has no problem at all paying its short term obligations.
ATEX has a Quick ratio of 2.23. This is amongst the best in the industry. ATEX outperforms 90.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 2.23
ATEX Yearly Current Assets VS Current LiabilitesATEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

4

3. Growth

3.1 Past

ATEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.59%, which is quite impressive.
ATEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.90%.
The Revenue has been growing by 31.05% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)27.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%196.08%
Revenue 1Y (TTM)43.9%
Revenue growth 3Y77.41%
Revenue growth 5Y31.05%
Sales Q2Q%10.24%

3.2 Future

ATEX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -85.27% yearly.
Based on estimates for the next years, ATEX will show a small growth in Revenue. The Revenue will grow by 2.11% on average per year.
EPS Next Y42.52%
EPS Next 2Y-85.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.31%
Revenue Next 2Y2.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ATEX Yearly Revenue VS EstimatesATEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
ATEX Yearly EPS VS EstimatesATEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

ATEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEX Price Earnings VS Forward Price EarningsATEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEX Per share dataATEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

ATEX's earnings are expected to decrease with -85.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-85.27%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ATEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ANTERIX INC

NASDAQ:ATEX (7/18/2025, 10:54:21 AM)

22.74

-0.04 (-0.18%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)06-24 2025-06-24/amc
Earnings (Next)08-04 2025-08-04
Inst Owners89.46%
Inst Owner Change0.01%
Ins Owners1.66%
Ins Owner Change-1.34%
Market Cap425.24M
Analysts82.22
Price Target89.25 (292.48%)
Short Float %5.18%
Short Ratio6.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)187.79%
Min EPS beat(2)171.14%
Max EPS beat(2)204.43%
EPS beat(4)2
Avg EPS beat(4)69.48%
Min EPS beat(4)-83.01%
Max EPS beat(4)204.43%
EPS beat(8)5
Avg EPS beat(8)62.41%
EPS beat(12)8
Avg EPS beat(12)64.83%
EPS beat(16)9
Avg EPS beat(16)25.13%
Revenue beat(2)0
Avg Revenue beat(2)-17.55%
Min Revenue beat(2)-20.4%
Max Revenue beat(2)-14.71%
Revenue beat(4)0
Avg Revenue beat(4)-13.23%
Min Revenue beat(4)-20.4%
Max Revenue beat(4)-4.87%
Revenue beat(8)1
Avg Revenue beat(8)-15.57%
Revenue beat(12)2
Avg Revenue beat(12)-14.22%
Revenue beat(16)3
Avg Revenue beat(16)-16.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-9.62%
EPS NQ rev (3m)-9.62%
EPS NY rev (1m)54.68%
EPS NY rev (3m)54.68%
Revenue NQ rev (1m)-2.72%
Revenue NQ rev (3m)-2.72%
Revenue NY rev (1m)-1.49%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 70.51
P/FCF N/A
P/OCF N/A
P/B 2.72
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-2.54
FCFYN/A
OCF(TTM)-1.56
OCFYN/A
SpS0.32
BVpS8.37
TBVpS-3.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.41%
ROE -7.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.03%
ROA(5y)-9.42%
ROE(3y)-7.34%
ROE(5y)-13.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3317.88%
Cap/Sales 301.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 2.23
Altman-Z -0.55
F-Score4
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)2427.57%
Cap/Depr(5y)1914.89%
Cap/Sales(3y)709.4%
Cap/Sales(5y)1241.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%196.08%
EPS Next Y42.52%
EPS Next 2Y-85.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.9%
Revenue growth 3Y77.41%
Revenue growth 5Y31.05%
Sales Q2Q%10.24%
Revenue Next Year1.31%
Revenue Next 2Y2.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-292.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-169.68%
OCF growth 3YN/A
OCF growth 5YN/A